Adalimumab-induced sensory vasculitic neuropathy.

Sim, Nicholas Keyi; Ismail, Azzam; Alam, Taimour; Shanmugarajah, Priya Devi

Sim, Nicholas Keyi; Ismail, Azzam; Alam, Taimour; Shanmugarajah, Priya Devi.

Affiliation

Sim NK; Department of Neurology, Calderdale and Huddersfield NHS Foundation Trust, Halifax, UK nicholas.sim1@nhs.net.
Ismail A; Department of Pathology, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
Alam T; Department of Clinical Neurophysiology, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
Shanmugarajah PD; Department of Neurology, Leeds Teaching Hospitals NHS Trust, Leeds, UK.

Drug Ther Bull ; 61(9): 140-143, 2023 09.

Article in En | MEDLINE | ID: mdl-36649976

Subject(s)

Adalimumab; Neuromuscular Diseases; Humans; Adalimumab/adverse effects; Neuromuscular Diseases/chemically induced

Key words

biological agents; clinical neurophysiology; peripheral nerve disease; unwanted effects / adverse reactions; vasculitis

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Adalimumab / Neuromuscular Diseases Limits: Humans Language: En Journal: Drug Ther Bull Year: 2023 Document type: Article

Fulltext

XML

PubMed Links

Search on Google